Our featured panelist for this post is Dr Rikrik Ilyas, Managing Director, Innogene Kalbiotech, Singapore. She will be speaking at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
Dr Rikrik Ilyas, MSc, PhD has over 25 years of experience in the field of R&D, Regulatory, Clinical Research, Business Development, Clinical Development and Commercialization. She has led Innogene Kalbiotech, a Singapore based Company and subsidiary of Kalbe Farma since its inception in 2003 as a company focusing in the acquisition, development and commercialization of biosimilars and innovative biotechnolgy drugs, especially in oncology. Capitalizing on personalised medicine approach, with products available in 8 countries and a phase III cancer vaccine in the pipeline, Innogene was awarded the 2010 Asia Pacific Frost and Sullivan Emerging Company in oncology in November 2010.
Dr Ilyas will be discussing about the following:
Panel: Mapping out the challenges and opportunities for clinical trials in South East Asia
1. Optimizing your clinical trial strategies for the changing environment and challenges in South East Asia
2. Growing your clinical trials in South East Asia with opportunities to increase trial efficiency
3. Modifying your clinical trial plan with a thorough understanding of Asian regulatory systems to maximize clinical trial progress